Antiretroviral treatment of HIV infected adults

被引：39

作者：

Deeks, Steven G. ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94110 USA

[2] San Francisco Gen Hosp, San Francisco, CA 94110 USA

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2006年 / 332卷 / 7556期

关键词：

RECOMMENDATIONS; LAMIVUDINE; THERAPY; ZIDOVUDINE; EFAVIRENZ; INDINAVIR; DISEASE;

D O I：

10.1136/bmj.332.7556.1489

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1489 / 1493

页数：5

共 25 条

[11] British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005) [J].

Gazzard, B .

HIV MEDICINE, 2005, 6 :1-61

[12] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [J].

Gulick, RM ;

Mellors, JW ;

Havlir, D ;

Eron, JJ ;

Gonzalez, C ;

McMahon, D ;

Richman, DD ;

Valentine, FT ;

Jonas, L ;

Meibohm, A ;

Emini, EA ;

Chodakewitz, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :734-739

[13] Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1:: 2003 recommendations of an international AIDS Society-USA panel [J].

Hirsch, MS ;

Brun-Vézinet, F ;

Clotet, B ;

Conway, B ;

Kuritzkes, DR ;

D'Aquila, RT ;

Demeter, LM ;

Hammer, SM ;

Johnson, VA ;

Loveday, C ;

Mellors, JW ;

Jacobsen, DM ;

Richman, DD .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (01) :113-128

[14] Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy [J].

Hogg, RS ;

Yip, B ;

Chan, KJ ;

Wood, E ;

Craib, KJP ;

O'Shaughnessy, MV ;

Montaner, JSG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (20) :2568-2577

[15]

Johnson Victoria A, 2005, Top HIV Med, V13, P125

[16] Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus [J].

Lawrence, J ;

Mayers, DL ;

Hullsiek, KH ;

Collins, G ;

Abrams, DI ;

Reisler, RB ;

Crane, LR ;

Schmetter, BS ;

Dionne, TJ ;

Saldanha, JM ;

Jones, MC ;

Baxter, JD .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (09) :837-846

[17] A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection [J].

Opravil, M ;

Hirschel, B ;

Lazzarin, A ;

Furrer, H ;

Chave, JP ;

Yerly, S ;

Bisset, LR ;

Fischer, M ;

Vernazza, P ;

Bernasconi, E ;

Battegay, M ;

Ledergerber, B ;

Günthard, H ;

Howe, C ;

Weber, R ;

Perrin, L .

JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (09) :1251-1260

[18] Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection:: Recommendations of an International AIDS Society-USA panel [J].

Schambelan, M ;

Benson, CA ;

Carr, A ;

Currier, JS ;

Dubé, MP ;

Gerber, JG ;

Grinspoon, SK ;

Grunfeld, C ;

Kotler, DP ;

Mulligan, K ;

Powderly, WG ;

Saag, MS .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (03) :257-275

[19]

*SMART STUD, 2006, 13 C RETR OPP INF 5

[20] Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults [J].

Staszewski, S ;

Morales-Ramirez, J ;

Tashima, KT ;

Rachlis, A ;

Skiest, D ;

Stanford, J ;

Stryker, R ;

Johnson, P ;

Labriola, DF ;

Farina, D ;

Manion, DJ ;

Ruiz, NM .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1865-1873

← 1 2 3 →